Health Antitrust
[McDermott Will & Schulte] shines particularly in the defense of antitrust claims in the healthcare and pharmaceuticals space.
– The Legal 500 US
Grounded in McDermott Will & Schulte’s approach of providing practical advice and tailored solutions, our health antitrust lawyers address the healthcare industry’s unique challenges with business-friendly strategies. Clients in this heavily regulated, rapidly evolving space turn to us for our creative defense of deals, government investigations and litigation.
We use pragmatic yet innovative tactics to respond to antitrust claims and risks. Our clients include:
- Pharmaceutical and medical device manufacturers
- Medical wholesaler distributors and group purchasing organizations (GPOs)
- Health InsurTech companies
- Hospitals and providers
- Payors
- Pharmacy benefit managers (PBMs)
- Health private equity firms
Deals
With the weight of our top-ranked healthcare law firm behind them, clients rely on and trust us to navigate highly complex antitrust issues. We guide them through the antitrust implications of mergers, acquisitions and joint ventures.
Thanks to our advocacy and other strategic actions, we have handled dozens of major US Federal Trade Commission (FTC) healthcare investigations that we guided through to close while avoiding any challenge. On the pulse of the FTC’s and US Department of Justice (DOJ)’s increasing focus on health antitrust issues, our team also advises on vertical and conglomerate mergers, serial acquisitions (e.g., rollups) and platform deals.
Government Investigations
Government agencies are ramping up their scrutiny of potential anti-competitive activity in the healthcare industry. Our health antitrust team stands prepared to represent clients through resulting investigations.
On behalf of our clients, we regularly handle investigations into allegations ranging from market allocation to criminal wage-fixing brought by the FTC, DOJ and state attorneys general – working swiftly and effectively to resolve inquiries.
Litigation
When we’re called upon to defend them, our clients know they are in the capable hands of first-chair litigators. Our team has decades of experience defending antitrust claims before courts around the United States.
Our track record includes successfully defending some of the largest health organizations against antitrust violations and class action litigation. However, we don’t just copy and paste the playbook from our past victories. We offer each client a tailored strategy supported by our extensive knowledge and unparalleled litigation skills to achieve the optimal result for their business.
Just one example of our industry-leading experience is McDermott Will & Schulte’s representation of a former senior executive at DaVita. In this first-ever criminal “no poach” market allocation case, we served as lead counsel from the outset of a DOJ investigation through the not-guilty jury verdict.
“They are responsive, practical, cost-effective, and have very good coverage in areas where we need advice.”
– Client testimonial, Chambers USA
“They are very thorough but practical. They listen and learn about the business and use that information in a valuable way through the merger process.”
The Legal 500 US
Ranked among the Top 20 Global Law Firms
Global Competition Review 100 2024
M&A
- Obtained antitrust clearance for the merger of the only two hospitals in Trenton, New Jersey
- Obtained antitrust clearance for the acquisition of a hospital in Jackson, Tennessee, by the other only hospital the area
- Obtained antitrust clearance for a $1.3 billion PBM acquisition despite a Second Request investigation by the FTC
- Obtained global antitrust clearance for the sale of a blood plasma products producer to a competitor in a cross-border transaction
- Achieved a favorable settlement for a leading hospital system’s affiliation with another hospital system after suing the California attorney general to set aside competitive conditions of approval
- Achieved a favorable settlement for a hospital’s partial interest acquisition of a competing hospital
- Served as antitrust counsel to Mountain States Health Alliance in obtaining approvals with antitrust immunity from Tennessee and Virginia for a merger with Wellmont Health System, over FTC staff opposition
- Represented a pharmaceutical company in obtaining FTC clearance in $6.4 billion combination with a public generics and specialty pharmaceutical company
Litigation
- In the DOJ’s first-ever criminal “no poach” labor antitrust trial, obtained acquittal for a former senior executive of major healthcare provider DaVita
- Representing Veradigm in antitrust class action alleging conspiracy to raise the price of prescription routing services
- Obtained summary judgment against unlawful exclusive dealing, tying and monopolization claims seeking in excess of $100 million in damages in a ruling affirmed by the Seventh Circuit
- Represented a pharmaceutical manufacturer in one of the largest price-fixing class actions in US history
- Defended Amgen against “bundling”/monopolization claims in a pharmaceutical products antitrust preliminary injunction action brought by Amgen’s competitor, Ortho
- Obtained summary judgment for Lake Forest Hospital in connection with a civil antitrust action alleging monopolization and attempted monopolization of various ancillary healthcare markets
- Obtained summary judgment for IDEXX, which the Ninth Circuit affirmed in monopolization and conspiracy claims arising out of alleged exclusive dealing contracts with distributors
- Successfully moved to dismiss a complaint by a competitor hospital alleging various federal and state antitrust violations in connection with competition in the Tennessee healthcare market
- Defended two teaching hospitals in Michigan in a class action purportedly on behalf of medical residents across the US alleging that all teaching hospitals conspired to set medical resident stipends in violation of Sherman Act Section 1
Investigations
- Representing private equity backed physician staffing company in state attorney general investigation of prior acquisitions and business practices
- Obtained a favorable resolution for an outpatient oncology provider in a market allocation investigation brought by a state attorney general
- Represented a regional hospital system in an FTC study of prior acquisition and business practices assessing potential anticompetitive effects
- Successfully represented a hospital system in a DOJ criminal grand jury investigation of alleged wage fixing for healthcare workers, which resulted in no indictment
Article, Client alert
FTC increases 2026 thresholds for HSR filings and interlocking directorates
Article, Client alert
“Mini-HSR” laws take effect in Washington and Colorado: Know when filings are required
Antitrust
Regulators are placing greater scrutiny on transactions, pricing practices, and competitor conduct. Our antitrust lawyers partner with you to pursue strategic growth opportunities while navigating regulatory pressure across global markets – helping you reduce the risk of business disruption, financial exposure, and reputational damage.
Our antitrust lawyers provide coordinated guidance across US and international competition laws. From strategic transactions and government investigations to commercial counseling and competition disputes, we work with you to manage antitrust risk wherever it arises.
We represent companies and individuals in antitrust investigations, enforcement actions, and competition disputes across US and international markets. Our lawyers advise you on matters involving the US Department of Justice (DOJ), Federal Trade Commission (FTC), European Commission, EU Member State authorities, and other global competition agencies. We guide you through cartel investigations, class actions, civil antitrust litigation, and other regulatory proceedings tied to antitrust and competition law.
We also help you navigate merger clearance, foreign investment reviews, competition approvals, and regulatory filing strategies. We regularly serve as specialized antitrust counsel focused on merger clearance and competition approvals in complex domestic and cross-border transactions.
Competition laws influence your day-to-day business operations. To help you manage risk under evolving antitrust requirements, our lawyers advise you on pricing strategies, distribution structures, competitor collaborations, trade association conduct, exclusive arrangements, and compliance programs. By understanding how regulators evaluate competitive conduct, we guide you to make informed business decisions that reduce antitrust exposure.
Antitrust and competition issues frequently involve overlapping considerations. Our antitrust lawyers partner with you to manage competition risk across jurisdictions. Whether you are pursuing a transaction, structuring a commercial arrangement, or responding to a government investigation, we help you navigate regulatory scrutiny strategically while protecting your ability to compete and grow across global markets.
Antitrust Litigation
They got great results for us in our toughest litigation. In court, they are fierce competitors and well-prepared advocates.
– Client Testimonial
McDermott Will & Schulte lawyers have been on many of the landmark antitrust litigation cases of this century. From securing summary judgment in the precedent-setting price-fixing chocolate confectionary litigation to prevailing on behalf of several hospital systems in the first batch of wage-fixing class actions, we have successfully litigated and defended on appeal the full gamut of novel antitrust cases.
Clients turn to us for our enviable track record in cutting-edge matters and unparalleled experience as lead counsel on actions involving:
- Price-fixing
- Cartels
- Monopolization
- Tying
- Dealer terminations
- Group boycotts and refusals to deal
- Exclusive dealing
- Antitrust counterclaims in patent and trademark litigation
- Litigated challenges to mergers and acquisitions
Our antitrust class action defense lawyers are some of the most experienced in the United States, and we are on the pulse of litigating private competition law damages claims in Europe. We regularly represent clients before foreign and domestic regulatory agencies, including the Federal Trade Commission (FTC), the US Department of Justice (DOJ), state attorneys general and the European Commission (EC) Directorate-General for Competition. We also represent clients in competition litigation in European Union and Member State courts.
Members of our team previously held key positions regulatory and law enforcement agencies, including the FTC, the DOJ and the EC.
Who We Represent
Understanding our clients’ industries is paramount to litigation success. Our experience encompasses most markets, and we regularly deliver results for clients from all sectors of the economy, including the following:
- Consumer products
- Food, beverage and agribusiness
- Healthcare
- Life sciences
- Financial services
- Insurance
- E-commerce
- Digital advertising
- Aerospace and defense
- Chemicals
- Energy
- Manufacturing
- Technology
Cartel Defense & Investigations
The firm performs at a very high level.
– Client Testimonial, Chambers USA
McDermott Will & Schulte has extensive experience successfully defending antitrust criminal cartel investigations at every step, including those brought by the US Department of Justice (DOJ). We recognize that targets of government cartel investigations and defendants in litigation need real-world options in a fast-paced, high-pressure environment.
The team’s record of success speaks to the quality and efficiency of our representation. We help clients respond immediately to coordinated actions of regulatory and law enforcement officials around the world (including so-called “dawn raids”).
Our areas of focus
Drawing on our firsthand knowledge of agency priorities and investigative procedures, we develop compelling arguments that demonstrate the validity and legality of our clients’ business practices. Our all-encompassing capabilities include:
- Handling amnesty and leniency applications
- Defending grand jury investigations
- Conducting thorough internal investigations to determine the facts, secure documents, ensure forensic evidence preservation and develop compelling defenses
- Securing the lowest fines and reaching non-prosecutorial agreements and immune status for individuals
- Successfully defending criminal trials
Our antitrust team also represents clients in follow-on civil litigation proceedings, helping clients navigate complex antitrust challenges and deliver optimal results.
EU Competition Law
Based in our Brussels office, McDermott Will & Schulte’s EU Competition team provides end-to-end antitrust and competition representation before the European Commission, other EU institutions and the various national competition authorities.
Our multilingual, multinational team of competition lawyers counsels clients on the entire spectrum of competition issues, including:
- Merger clearance, including structuring and presenting transactions, managing notification processes for multinational transactions, and developing timely, cost-effective strategies for obtaining regulatory clearance
- Cartels, including providing coordinated advice in the EU, United States and elsewhere to defend international cartel investigations and prosecutions
- Horizontal and vertical agreements, including advising on joint research and development, standardization, and supply and distribution agreements
- Abuse of dominance, including defense of companies against regulatory allegations and private complaints of infringement, and pursuing redress on behalf of clients victimized by dominant competitors and suppliers
- State aid, including analyzing the legal situation and drafting documents
- Compliance, including performing competition law compliance audits and helping clients address related regulations involving commercial bribery, data protection, privacy, trade and intellectual property
- Competition litigation, including providing sophisticated defense of clients in national and EU courts in class actions and multi-jurisdictional proceedings.
Our clients include many of the premier international enterprises whose products are major household names, as well as many of the world’s top manufacturers, suppliers, distributors and service providers. We have firsthand experience and a deep understanding of the industries in which our clients operate, including life sciences, chemicals, energy, food and beverages, manufacturing, technology and networks.
Merger Clearance
[McDermott Will & Schulte has] considerable expertise in handling complicated merger clearances.
– Chambers USA
Our team's global antitrust and competition team has extensive experience in all facets of the merger review process. We understand the concerns of business leaders and regulators alike across the world and have a reputation for success in even the most difficult, complex deals.
Companies need to navigate multiple regulatory regimes to complete their M&A transactions, including antitrust reviews, foreign investment notifications and foreign subsidies regulation. Our team's practical, efficient advice helps clients navigate these regimes and delivers successful outcomes to get their deals closed. With lawyers in the United States, the United Kingdom, Germany, France and Belgium, our team prepares our clients for merger regulatory trends and new regimes.
Antitrust/Competition Law Filings and Clearance
In the increasingly complex regulatory landscape, businesses must have a captain with the experience necessary to handle government investigations and coordinate across filing regimes.
We regularly defend clients in merger-related antitrust investigations and inquiries before the US Federal Trade Commission (FTC), the US Department of Justice (DOJ), the European Commission (EC) and other international jurisdictions. We work hand-in-hand with clients at every step, from the earliest transaction consideration through the initial waiting period and, when required, compliance with agency requests for additional information, including “second requests.” When necessary, we vigorously defend transactions in court.
We also represent third parties that wish to oppose transactions before the FTC, DOJ and regulatory bodies in other major jurisdictions, and we manage local counsel effectively when filings are required in locations where we do not have an office. In addition, we assist companies in obtaining regulatory clearance for their purchase of assets being sold under a divesture order. For example, we represented FactSet in obtaining EC-suitable purchaser approval for its acquisition of S&P’s CUSIP Global Services business for $1.9 billion when that business had to be divested to resolve EC concerns with the merger between S&P and IHS Markit.
Clients value our ability to overcome regulatory hurdles and to do so quickly. The key to our success is our technically skilled and practically oriented team, including many former regulators with outstanding relationships with investigators and prosecutors. Globally, we anticipate issues rather than wait for regulators to find problems. We learn the industry and clearly communicate with agency staff so that we can address issues early on and avoid a lengthy investigation where possible.
We continue to explore creative ways to obtain merger clearances swiftly and efficiently. For example, we obtained a very rare derogation (non-enforcement) of the premerger waiting period in an acquisition that needed to be closed very rapidly to comply with European Union (EU) regulations arising from the ongoing conflict in Ukraine. Our team brings significant depth in navigating the multifaceted and complex intricacies of compliance with the Hart-Scott-Rodino Act (HSR) and multijurisdictional merger filing analysis. We have a large HSR team, headed by a former member of the FTC’s Premerger Notification Office who is highly skilled in assessing transactions for reportability, reporting and expediting transactions wherever possible. Our team is one of the most frequent filers, and we recently made over 100 HSR filings in a single year.
Foreign Direct Investment
The number of jurisdictions imposing foreign direct investment (FDI) filing requirements is growing substantially in light of changing geopolitical dynamics and the increasing use of cross-border restrictions to support national security interests. Our team has the practical know-how to navigate FDI regimes around the world to manage the filing strategy for our clients wherever needed. Clients benefit from leveraging not only our in-house global team but also our strong relationships with peer firms and local experts across the world. We provide prefiling screenings for reportability and lead the filing process from start to finish.
Foreign Subsidies Regulation
The EU Foreign Subsidies Regulation (FSR) implemented in 2023 presents an unprecedented regulatory obstacle for global M&A transactions. We guide clients through the additional hurdles and mandatory filing requirements and advise on developing and implementing proactive tracking procedures for financial contributions received from non-EU member states to allow companies to comply with the new regulation.
Health & Life Sciences
Healthcare and life sciences companies operate under the most difficult circumstances. They face pressure to drive innovation and growth while navigating intense government oversight and stakeholder scrutiny. Our lawyers guide you through critical business decisions, complex regulatory frameworks, and evolving market pressures – so you can lead transformation in a highly regulated environment.
Year after year, we are named “Healthcare Practice Group of the Year” by Law360 and ranked by PitchBook as the #1 law firm advising healthcare private equity investors. As one of the top healthcare law firms in the US, we represent every major stakeholder in the ecosystem – from healthcare providers and health systems to life sciences companies and investors.
Our global team delivers integrated legal counsel across regulatory, transactional, intellectual property, litigation, and other business-critical matters. Having served in leadership roles both in-house and within government, we provide the legal, commercial, and regulatory guidance you need across health and life sciences law to shape the future of the industry.
Our health and life sciences lawyers have held senior roles across key government agencies including the US Food and Drug Administration (FDA), Federal Trade Commission (FTC), Department of Health and Human Services (HHS), and Department of Justice (DOJ) – giving us unique insight into the enforcement challenges you face.
We don’t just understand how regulations are enforced – we know how healthcare policy is developed. Through McDermott+, our dedicated healthcare policy and strategic advisory arm, we help you navigate and shape the policy landscape that influences the industry. With a team that includes lawyers, physicians, policy professionals, data analysts, and veterans of Capitol Hill, we advocate for policies that support your healthcare mission.
Our lawyers also guide you across the life cycle of transformative deals, from formation and financing to commercialization, partnerships, and exit. We help you structure transactions that are aligned with market realities and designed to deliver long-term value.
From securing investment and commercializing innovation to scaling operations and protecting your market position, we support you at every stage of growth. Our team develops integrated legal strategies that help clear the path for your breakthrough technologies, next-generation therapeutics, AI-enabled healthcare solutions, and innovative care delivery models.
Disclaimer
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.